CN104208212A - Chinese medicinal wine for treating hemiplegia and preparation method thereof - Google Patents
Chinese medicinal wine for treating hemiplegia and preparation method thereof Download PDFInfo
- Publication number
- CN104208212A CN104208212A CN201410495744.5A CN201410495744A CN104208212A CN 104208212 A CN104208212 A CN 104208212A CN 201410495744 A CN201410495744 A CN 201410495744A CN 104208212 A CN104208212 A CN 104208212A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicinal
- chinese
- liquor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal wine for treating hemiplegia and a preparation method thereof. The Chinese medicinal wine is prepared from the following raw materials of, by weight, 1 part of aconite roots, 1 part of aconitine, 1 part of fructus chaenomelis, 1 part of honeysuckle, 1 part of radix cyathulae, 1 part of Chinese angelica, 1 part of radix stephaniae tetrandrae, 1 part of dark plum fruit, 1 part of radix gentianae macrophyllae, 1 part of scorpion, 1-2 parts of centipede, 18-22 parts of crystal sugar, and 170-199 parts of white spirits, wherein the weight ratio of the aconite roots, the bighead atractylodes rhizome, to eucommia barks is 9: 13: 13, the volume of the white spirits in the Chinese medicinal wine ranges from 42%(V/V) to 56%(V/V), and the raw materials are placed in a wine jar. According to the Chinese medicinal wine for treating hemiplegia, natural Chinese herbal medicine is used according to compatibility mechanisms of a monarch, a minister, an assistant and a guide, the Chinese medicinal wine is capable of promoting blood circulation to remove blood stasis, eliminating evil, promoting inner mechanisms of the bodies, and effectively treating hemiplegia, complications of hemiplegia, and sequelae, and the Chinese medicinal wine is innovative medicine for treating hemiplegia.
Description
Technical field
The present invention relates to a kind of Chinese medicinal liquor, especially relate to a kind of Chinese medicinal liquor for the treatment of hemiplegia and preparation method thereof.
Background technology
Along with living standards of the people improve constantly, take in the food of more and more higher fatty acid, high heat, high protein in body, the probability making middle-aged and elderly people suffer from diabetes or apoplexy increases greatly, once morbidity, need immediately to be sent to hospital admission or hospitalization, at present, hospital's many employings Western medicine is treated, not only expensive, and effect is not satisfactory, once delay treatment opportunity, will hemiplegia be caused, cause lifelong regret.Therefore, how prophylactic treatment hemiplegia is the problem of hospital's active research.
If application number is the Chinese medicinal liquor that all refer to preparation treatment hemiplegia in 200810085994.6,201210596903.1,200810022171.9, and this has expelling pathogenic wind from the body surface all to contain Radix Saposhnikoviae in such Chinese medicinal liquor, the Chinese crude drug of removing dampness to relieve pain.
Summary of the invention
The invention discloses Chinese medicinal liquor of a kind for the treatment of hemiplegia not containing Radix Saposhnikoviae and preparation method thereof, even if make Chinese medicinal liquor of the present invention also can not reach the effect for the treatment of hemiplegia containing Radix Saposhnikoviae.
Technical scheme of the present invention is, a kind of Chinese medicinal liquor for the treatment of hemiplegia, comprise following raw material: Radix Aconiti, Radix Aconiti Kusnezoffii, Fructus Chaenomelis, Flos Lonicerae, Radix Cyathulae, Radix Angelicae Sinensis, Radix Stephaniae Tetrandrae, Fructus Mume, Radix Gentianae Macrophyllae, Scorpio, the Rhizoma Atractylodis Macrocephalae, the Cortex Eucommiae, Scolopendra, crystal sugar and Chinese liquor, wherein: Radix Aconiti: Radix Aconiti Kusnezoffii: Fructus Chaenomelis: Flos Lonicerae: Radix Cyathulae: Radix Angelicae Sinensis: Radix Stephaniae Tetrandrae: Fructus Mume: Radix Gentianae Macrophyllae: Scorpio: Scolopendra: crystal sugar: the weight ratio of Chinese liquor is 1:1:1:1:1:1:1:1:1:1:1-2:18-22:170-199, Radix Aconiti: the Rhizoma Atractylodis Macrocephalae: the weight ratio of the Cortex Eucommiae is 9:13:13, the number of degrees of Chinese liquor used are within the scope of 42-56.
As a kind of preferred implementation, this Chinese medicinal liquor comprises following raw material: Radix Aconiti 18 parts, Radix Aconiti Kusnezoffii 18 parts, Fructus Chaenomelis 18 parts, Flos Lonicerae 18 parts, Radix Cyathulae 18 parts, Radix Angelicae Sinensis 18 parts, Radix Stephaniae Tetrandrae 18 parts, Fructus Mume 18 parts, Radix Gentianae Macrophyllae 18 parts, Scorpio 18 parts, the Rhizoma Atractylodis Macrocephalae 26 parts, the Cortex Eucommiae 26 parts, Scolopendra 25-36 part, crystal sugar 330-380 part, Chinese liquor 3100-3500 part, the number of degrees of Chinese liquor used are within the scope of 46-52.
As a kind of preferred implementation, this Chinese medicinal liquor comprises following raw material: Radix Aconiti 18 parts, Radix Aconiti Kusnezoffii 18 parts, Fructus Chaenomelis 18 parts, Flos Lonicerae 18 parts, Radix Cyathulae 18 parts, Radix Angelicae Sinensis 18 parts, Radix Stephaniae Tetrandrae 18 parts, Fructus Mume 18 parts, Radix Gentianae Macrophyllae 18 parts, Scorpio 18 parts, the Rhizoma Atractylodis Macrocephalae 26 parts, the Cortex Eucommiae 26 parts, Scolopendra 30 parts, 350 parts, crystal sugar, 52 ° of Chinese liquor 3500 parts.
As a kind of preferred implementation, this Chinese medicinal liquor comprises following raw material: Radix Aconiti 18 parts, Radix Aconiti Kusnezoffii 18 parts, Fructus Chaenomelis 18 parts, Flos Lonicerae 18 parts, Radix Cyathulae 18 parts, Radix Angelicae Sinensis 18 parts, Radix Stephaniae Tetrandrae 18 parts, Fructus Mume 18 parts, Radix Gentianae Macrophyllae 18 parts, Scorpio 18 parts, the Rhizoma Atractylodis Macrocephalae 26 parts, the Cortex Eucommiae 26 parts, Scolopendra 30 parts, 360 parts, crystal sugar, 48 ° of Chinese liquor 3500 parts.
The production method of this Chinese medicinal liquor is: above-mentioned medical material is loaded wine jar, after adding crystal sugar and Chinese liquor in proportion again, Feng Tan, puts into pot, and slow fire boils 1-3h, again wine jar is taken out, put into heatable adobe sleeping platform, then with a china bowl, altar lid is lived, then banket, tread, take out after 24-48h, the Chinese medicinal liquor of the hemiplegia that namely obtains medical treatment.
As a kind of preferred implementation, above-mentioned medical material is loaded wine jar, then after adding crystal sugar and Chinese liquor in proportion, Feng Tan, put into pot, slow fire boils 1h, then is taken out by wine jar, puts into heatable adobe sleeping platform, then with a china bowl, altar lid is lived, then banket, tread, take out after 24h, the Chinese medicinal liquor of the hemiplegia that namely obtains medical treatment.
The present invention defers to the compatibility mechanism of monarch, monarch drug has Radix Aconiti, Radix Aconiti Kusnezoffii, Scolopendra, Scorpio, the Rhizoma Atractylodis Macrocephalae, the Cortex Eucommiae, wherein Radix Aconiti, Radix Aconiti Kusnezoffii, Scolopendra, Scorpio has anemofrigid-damp arthralgia, arthralgia, endogenous wind stopping spasmolytic, merit poison eliminating stagnation, the poisonous medical material of removing obstruction in the collateral to relieve pain, the proportioning of effective control four kinds of toxicity medical materials, its toxicity is disappeared mutually, reduce the toxic and side effects of Chinese medicine, Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI, dampness diuretic, Cortex Eucommiae invigorating the liver and kidney, bone and muscle strengthening, by dredging spleen, stomach, liver, kidney channel network, the drug effect of above-mentioned six kinds of Chinese medicines is excited by Chinese liquor, the primary symptom of effective treatment hemiplegia.Ministerial drug has Fructus Chaenomelis, Flos Lonicerae, Radix Stephaniae Tetrandrae, Radix Gentianae Macrophyllae, for effect of dredging the meridian, expelling wind and activating blood circulation pain relieving, removing dampness and relaxing myospasm, warm blood fulminant dysentery, clearind deficient heat, strengthens the therapeutic effect of hemiplegia the person in charge for auxiliary ministerial drug.Adjuvant drug has Radix Angelicae Sinensis, Fructus Mume, for blood circulation promoting and enriching, astringes the lung and promotes the production of body fluid, conditioning liver, the heart, spleen, lung, large intestine meridians, plays auxiliary monarch drug, therapeutical effect strengthened by ministerial drug.Medicine is made to have Radix Cyathulae, for coordinating the actions of various ingredients in a prescription, make monarch drug, ministerial drug, adjuvant drug eliminating evil with joint efforts, utilize there is cold expelling gas, help the efficacy of a drug, the drug effect of above-mentioned Chinese crude drug excites by the Chinese liquor of blood circulation and channel invigorating, crystal sugar has the effect of invigorating the spleen and replenishing QI, is mainly used in the mouthfeel improving Chinese medicinal liquor here.
Detailed description of the invention
Below in conjunction with embodiment, the specific embodiment of the present invention is further described.
Embodiment 1.
A kind of Chinese medicinal liquor for the treatment of hemiplegia, comprise following raw material: Radix Aconiti 18g, Radix Aconiti Kusnezoffii 18g, Fructus Chaenomelis 18g, Flos Lonicerae 18g, Radix Cyathulae 18g, Radix Angelicae Sinensis 18g, Radix Stephaniae Tetrandrae 18g, Fructus Mume 18g, Radix Gentianae Macrophyllae 18g, Scorpio 18g, Rhizoma Atractylodis Macrocephalae 26g, Cortex Eucommiae 26g, Scolopendra 30g, crystal sugar 350g, 52 ° of Chinese liquor 3500g, above-mentioned medical material is loaded wine jar, after adding crystal sugar and Chinese liquor in proportion again, Feng Tan, put into pot, slow fire boils 1h, again wine jar is taken out, put into heatable adobe sleeping platform, then with a china bowl, altar lid is lived, then banket, tread, take out after 24h, the Chinese medicinal liquor of the hemiplegia that namely obtains medical treatment.
Embodiment 2.
A kind of Chinese medicinal liquor for the treatment of hemiplegia, comprise following raw material: Radix Aconiti 18g, Radix Aconiti Kusnezoffii 18g, Fructus Chaenomelis 18g, Flos Lonicerae 18g, Radix Cyathulae 18g, Radix Angelicae Sinensis 18g, Radix Stephaniae Tetrandrae 18g, Fructus Mume 18g, Radix Gentianae Macrophyllae 18g, Scorpio 18g, Rhizoma Atractylodis Macrocephalae 26g, Cortex Eucommiae 26g, Scolopendra 30g, crystal sugar 360g, 48 ° of Chinese liquor 3500g, above-mentioned medical material is loaded wine jar, after adding crystal sugar and Chinese liquor in proportion again, Feng Tan, put into pot, slow fire boils 1h, again wine jar is taken out, put into heatable adobe sleeping platform, then with a china bowl, altar lid is lived, then banket, tread, take out after 36h, the Chinese medicinal liquor of the hemiplegia that namely obtains medical treatment.
1 case-data.
Observe case totally 80 examples, patient is outpatient service and the admissions office patient of certain academy of traditional Chinese medicine, and single-blind randomized is divided into treatment group and matched group 2 groups, often organizes each 40 examples.In treatment group man 25 example, female 15 example, age 42-85 year, the mean age is 64.1 years old, the course of disease 3 days-10 months, average 3 months.In matched group man 21 example, female 19 example, age 41-86 year, the mean age is 64.7 years old, the course of disease 3 days-10 months, average 2.9 months.Two groups are compared at sex, age, the course of disease, coincident with severity degree of condition and accompanying diseases etc., and no significant difference (P >=0.05), has comparability.
2 Therapeutic Method.
2.1 matched groups give western medicine routine treatment; because doctor trained in Western medicine claims hemiplegia to be apoplexy sequela; therefore employing brain is protected, improved the measure such as cerebral circulation, trophic nerve, accompanied with hypertension, diabetes, coronary disease patient give blood pressure lowering, control the process such as blood glucose and coronary dilating.Ischemic Stroke adds antiplatelet aggregation, anticoagulant therapy.
2.2 treatment groups coordinate Chinese medicinal liquor of the present invention on matched group basis, 3 times on the one, once take 30g-50g,
10 days is a course for the treatment of, takes and can take effect 3-10 the course for the treatment of, and consumption can make the appropriate adjustments according to patient age, body weight, the type and the order of severity etc. of disease for the treatment of.
3 observation index.
3. 1 curative effect index patient subjective symptoms, records respectively to the symptom before and after patient treatment, passes judgment on therapeutic effect according to criterion of cure, effectively standard.
3. the general health check-up project of 2 safety indexes (body temperature, breathing, pulse, blood pressure), hematuria stool routine, darling renal function inspections etc., to begin a project all before medication and terminate rear each inspection each course for the treatment of once, observe untoward reaction at any time.
4 criterions of therapeutical effect and therapeutic outcome.
" Chinese medical disease Standardization of diagnosis and curative effect " that 4.1 standards are promulgated with reference to State Administration of Traditional Chinese Medicine for 2012 determines following standard: criterion of cure can independently be walked about for patient need not lean on crutch completely, walk with firm steps, can more clear dialogue, memory is recovered better, upper limb is strong, hand held object ability strengthens greatly, and life reaches self-care completely; Effective standard is for after taking 3 courses for the treatment of, and the state of an illness is effectively improved, and walks, speaks, the obstacle such as affective interaction disappears substantially, substantially no longer have sequela, can be engaged in simple housework.
4.2 liang of group patient comparitive study, in table 1.
As seen from Table 1, in the routine patient for the treatment of group 40, cure 27 examples, effective 10 examples, invalid 3 examples, total effective rate is 92.5%; In the routine patient of matched group 40, cure 20 examples, effective 8 examples, invalid 12 examples, total effective rate is 70%.
Table 1 liang group patient comparitive study.
| Group | Cure | Effectively | Invalid | Total effective rate |
| Treatment group (40) | 27 | 10 | 3 | 92.5% |
| Matched group (40) | 20 | 8 | 12 | 70% |
4.3 safety indexes are observed.
Before and after this clinical observation treatment, two groups of general health check-up projects of patient, the inspection of hematuria stool routine, cardiac inspections etc. have no significant change.Viewing duration, two groups there is not serious adverse events during this clinical observation.Through t inspection, before and after two groups of treatments, hepatic and renal function and routine blood test index of correlation are all without significant difference.
Visible, Western medicine coordinates Chinese medicinal liquor of the present invention more can significantly improve the curative effect of hemiplegia than simple doctor trained in Western medicine Primary Care, and there is not side effect, and patient compliance is good, has actual clinical meaning.
Claims (6)
1. treat the Chinese medicinal liquor of hemiplegia for one kind, it is characterized in that the Chinese medicinal liquor be made up in proportion of following raw material: Radix Aconiti, Radix Aconiti Kusnezoffii, Fructus Chaenomelis, Flos Lonicerae, Radix Cyathulae, Radix Angelicae Sinensis, Radix Stephaniae Tetrandrae, Fructus Mume, Radix Gentianae Macrophyllae, Scorpio, the Rhizoma Atractylodis Macrocephalae, the Cortex Eucommiae, Scolopendra, crystal sugar and Chinese liquor, wherein: Radix Aconiti: Radix Aconiti Kusnezoffii: Fructus Chaenomelis: Flos Lonicerae: Radix Cyathulae: Radix Angelicae Sinensis: Radix Stephaniae Tetrandrae: Fructus Mume: Radix Gentianae Macrophyllae: Scorpio: Scolopendra: crystal sugar: the weight ratio of Chinese liquor is 1:1:1:1:1:1:1:1:1:1:1-2:18-22:170-199, Radix Aconiti: the Rhizoma Atractylodis Macrocephalae: the weight ratio of the Cortex Eucommiae is 9:13:13, the number of degrees of Chinese liquor used are within the scope of 42-56.
2. the Chinese medicinal liquor for the treatment of hemiplegia as claimed in claim 1, it is characterized in that the Chinese medicinal liquor be made up in proportion of following raw material: Radix Aconiti 18 parts, Radix Aconiti Kusnezoffii 18 parts, Fructus Chaenomelis 18 parts, Flos Lonicerae 18 parts, Radix Cyathulae 18 parts, Radix Angelicae Sinensis 18 parts, Radix Stephaniae Tetrandrae 18 parts, Fructus Mume 18 parts, Radix Gentianae Macrophyllae 18 parts, Scorpio 18 parts, the Rhizoma Atractylodis Macrocephalae 26 parts, the Cortex Eucommiae 26 parts, Scolopendra 25-36 part, crystal sugar 330-380 part, Chinese liquor 3100-3500 part.
3. the Chinese medicinal liquor for the treatment of hemiplegia as claimed in claim 1, it is characterized in that the Chinese medicinal liquor be made up in proportion of following raw material: Radix Aconiti 18 parts, Radix Aconiti Kusnezoffii 18 parts, Fructus Chaenomelis 18 parts, Flos Lonicerae 18 parts, Radix Cyathulae 18 parts, Radix Angelicae Sinensis 18 parts, Radix Stephaniae Tetrandrae 18 parts, Fructus Mume 18 parts, Radix Gentianae Macrophyllae 18 parts, Scorpio 18 parts, the Rhizoma Atractylodis Macrocephalae 26 parts, the Cortex Eucommiae 26 parts, Scolopendra 30 parts, 350 parts, crystal sugar, 52 ° of Chinese liquor 3500 parts.
4. the Chinese medicinal liquor for the treatment of hemiplegia as claimed in claim 1, it is characterized in that the Chinese medicinal liquor be made up in proportion of following raw material: Radix Aconiti 18 parts, Radix Aconiti Kusnezoffii 18 parts, Fructus Chaenomelis 18 parts, Flos Lonicerae 18 parts, Radix Cyathulae 18 parts, Radix Angelicae Sinensis 18 parts, Radix Stephaniae Tetrandrae 18 parts, Fructus Mume 18 parts, Radix Gentianae Macrophyllae 18 parts, Scorpio 18 parts, the Rhizoma Atractylodis Macrocephalae 26 parts, the Cortex Eucommiae 26 parts, Scolopendra 30 parts, 360 parts, crystal sugar, 48 ° of Chinese liquor 3500 parts.
5. the preparation method of arbitrary described Chinese medicinal liquor in claim 1-4, it is characterized in that: above-mentioned medical material is loaded wine jar, then after adding crystal sugar and Chinese liquor in proportion, Feng Tan, put into pot, slow fire boils 1-3h, then is taken out by wine jar, puts into heatable adobe sleeping platform, then with a china bowl, altar lid is lived, then banket, tread, take out after 24-48h, the Chinese medicinal liquor of the hemiplegia that namely obtains medical treatment.
6. preparation method as claimed in claim 5, it is characterized in that: above-mentioned medical material is loaded wine jar, then after adding crystal sugar and Chinese liquor in proportion, Feng Tan, put into pot, slow fire boils 1h, then is taken out by wine jar, puts into heatable adobe sleeping platform, then with a china bowl, altar lid is lived, then banket, tread, take out after 24h, the Chinese medicinal liquor of the hemiplegia that namely obtains medical treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410495744.5A CN104208212A (en) | 2014-09-25 | 2014-09-25 | Chinese medicinal wine for treating hemiplegia and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410495744.5A CN104208212A (en) | 2014-09-25 | 2014-09-25 | Chinese medicinal wine for treating hemiplegia and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104208212A true CN104208212A (en) | 2014-12-17 |
Family
ID=52090385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410495744.5A Pending CN104208212A (en) | 2014-09-25 | 2014-09-25 | Chinese medicinal wine for treating hemiplegia and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104208212A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106620494A (en) * | 2017-02-16 | 2017-05-10 | 成都富豪斯生物科技有限公司 | Internal medicine wine for treating hemiplegia and preparation method thereof |
| CN107213412A (en) * | 2017-07-14 | 2017-09-29 | 陈瑞莲 | A kind of medicament for specially controlling hemiplegia |
| CN111956723A (en) * | 2020-09-16 | 2020-11-20 | 邵朋 | Medicinal liquor for treating cerebral infarction apoplexy sequela and preparation method and application thereof |
-
2014
- 2014-09-25 CN CN201410495744.5A patent/CN104208212A/en active Pending
Non-Patent Citations (2)
| Title |
|---|
| 吴民方: "献上两个单方 ", 《小康生活》 * |
| 吴民方: "献上两个单方", 《小康生活》, no. 04, 31 December 1996 (1996-12-31), pages 54 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106620494A (en) * | 2017-02-16 | 2017-05-10 | 成都富豪斯生物科技有限公司 | Internal medicine wine for treating hemiplegia and preparation method thereof |
| CN107213412A (en) * | 2017-07-14 | 2017-09-29 | 陈瑞莲 | A kind of medicament for specially controlling hemiplegia |
| CN111956723A (en) * | 2020-09-16 | 2020-11-20 | 邵朋 | Medicinal liquor for treating cerebral infarction apoplexy sequela and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104208212A (en) | Chinese medicinal wine for treating hemiplegia and preparation method thereof | |
| CN103394031A (en) | Medicament for treating sciatica | |
| CN103830482B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of apoplexy | |
| CN103768324A (en) | Traditional Chinese medicine composition for treating hand and foot cold | |
| CN103948663B (en) | A kind of Chinese medicine composition, preparation method and applications | |
| CN105497506A (en) | Medicine for treating tinea pedis | |
| CN1843441A (en) | Rheumatism-eliminating collaterals-dredging externally applied plaster | |
| CN105434649A (en) | Traditional Chinese medicine composition treating blood-stasis collateral-obstruction type diabetic foot | |
| CN108126008A (en) | Rosemary cordyceps sinensis ball | |
| CN106109595A (en) | A kind of Chinese medicinal foot bath powder of anti-bacterial, anti-itching | |
| CN117338889B (en) | Essential oil composition for preventing and treating blood stasis syndrome and application thereof | |
| CN103239605B (en) | Chinese medicine effective part composition for treating hyperostosis and preparation method of Chinese medicine effective part composition | |
| CN106822271A (en) | It is a kind of to treat pharmaceutical composition of rheumatic Bi syndrome and its production and use | |
| CN103301216B (en) | Ant cervical spondylosis recovering oil liniment and preparation method thereof | |
| CN107519343A (en) | A kind of Chinese drugs agentia for being used to treat nettle rash | |
| CN104435979B (en) | A kind of medicine for treating rheumatic lumbocrural pain pain | |
| CN104971210A (en) | External lotion for treating tinea pedis and preparation method thereof | |
| CN105147861A (en) | Traditional Chinese medicinal composition and oral preparation for treating viral skin diseases and preparation method of oral preparation | |
| CN105434818A (en) | Traditional Chinese medicine preparation for treating cervical spondylosis | |
| CN117503898A (en) | Traditional Chinese medicine composition for treating asthma and application thereof | |
| CN107929496A (en) | Treat pharmaceutical composition of rheumatic arthritis and preparation method thereof | |
| CN104784454A (en) | Traditional Chinese medicine for treating hyperthyroidism | |
| CN104840624A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN103432397B (en) | Traditional Chinese medicine effective part composition for treating thromboangiitis obliterans | |
| CN103768150A (en) | Traditional Chinese medicine effective part composition for treating cataract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141217 |
|
| RJ01 | Rejection of invention patent application after publication |